Michael Højby Rasmussen

18PUBLICATIONS
35CO-AUTHORS
PharmacogenomicsInfant and child healthPharmaceutical delivery technologiesClinical pharmacology and therapeuticsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 29, 2026
Model-based somapacitan dosing and IGF-I response in children born SGA or with ISS, Noonan or Turner syndromes.

|Mar 05, 2026
Somapacitan in children born small for gestational age: a randomized controlled phase 3 trial.

Agnès Linglart, Volker Böttcher, Michael Højby

|Mar 03, 2026
Once-weekly somapacitan in children with Noonan syndrome: randomized controlled phase 3 trial.

Alexander A L Jorge, Assunta Albanese, Michael Højby

|Feb 19, 2026
Somapacitan in children with idiopathic short stature: a randomized controlled phase 3 study.

Jennifer Abuzzahab, Andrew Dauber, Michael Højby

|Jan 30, 2026
Somapacitan in children born small for gestational age: 4-year results from phase 2.

Anders Juul, Michael Højby, Masanobu Kawai

|May 22, 2025
Efficacy, safety, and insulin-like growth factor I of weekly somapacitan in children with growth hormone deficiency: 3-year results from REAL4.

Bradley S Miller, Joanne C Blair, Michael Højby Rasmussen

Pageof 3

Frequent Collaborators

8 joint publications

Jun Mori

4 joint publications

Rasmus Juul Kildemoes

4 joint publications

Bradley S Miller

4 joint publications

Agnès Linglart